New injectable drug shows promise for tough lung cancer
NCT ID NCT06598306
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-phase trial is testing a drug called tarlatamab, given as a shot under the skin, for people with extensive stage small cell lung cancer that has worsened after standard chemotherapy. The main goals are to check safety and side effects, and to see how the drug behaves in the body. About 220 adults will take part in this study.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- tarlatamab (a drug given as a shot under the skin)
- What this could lead to
- If it works, this could offer a more convenient way to treat small cell lung cancer that has spread and stopped responding to standard chemotherapy.
- What could go wrong
- This is an early Phase 1b trial focused on safety, not yet on effectiveness. The drug may cause side effects or not shrink tumors. Results are preliminary and may not lead to a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE-STAGE SMALL-CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Adana Sehir Egitim ve Arastirma Hastanesi
RECRUITINGAdana, 01370, Turkey (Türkiye)
-
Ankara Bilkent Sehir Hastanesi
RECRUITINGAnkara, 06800, Turkey (Türkiye)
-
Avera Cancer Institute
RECRUITINGSioux Falls, South Dakota, 57105, United States
-
Calvary Mater Newcastle Hospital
RECRUITINGWaratah, New South Wales, 2298, Australia
-
Centre Hospitalier Universitaire de Liege - Sart Tilman
RECRUITINGLiège, 4000, Belgium
-
Chris OBrien Lifehouse
RECRUITINGCamperdown, New South Wales, 2050, Australia
-
Freiburg Spital
RECRUITINGFribourg, 1708, Switzerland
-
Hospital Regional Universitario de Malaga
RECRUITINGMálaga, Andalusia, 29011, Spain
-
Hospital Universitari Vall d Hebron
RECRUITINGBarcelona, Catalonia, 08035, Spain
-
Hospital Universitari i Politecnic La Fe
RECRUITINGValencia, Valencia, 46026, Spain
-
Hospital Universitario 12 de Octubre
RECRUITINGMadrid, 28041, Spain
-
Instytut Centrum Zdrowia Matki Polki
RECRUITINGLodz, 93-338, Poland
-
Jilin Cancer Hospital
RECRUITINGChangchun, Jilin, 130012, China
-
Kantonsspital Graubuenden
RECRUITINGChur, 7000, Switzerland
-
Kantonsspital Winterthur
RECRUITINGWinterthur, 8401, Switzerland
-
Koc Universitesi Hastanesi
RECRUITINGIstanbul, 34010, Turkey (Türkiye)
-
Okayama University Hospital
RECRUITINGOkayama, Okayama-ken, 700-8558, Japan
-
Shanghai Pulmonary Hospital
RECRUITINGShanghai, Shanghai Municipality, 200433, China
-
Swedish Cancer Institute
RECRUITINGSeattle, Washington, 98104, United States
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, 3004, Australia
-
Trinity Health Saint Joseph Mercy Ann Arbor
RECRUITINGAnn Arbor, Michigan, 48106, United States
-
Universitaetsklinikum Regensburg
RECRUITINGRegensburg, 93053, Germany
-
Universitaetsklinikum Wuerzburg
RECRUITINGWürzburg, 97078, Germany
-
Universitair Ziekenhuis Gent
RECRUITINGGhent, 9000, Belgium
-
Universitair Ziekenhuis Leuven - Campus Gasthuisberg
RECRUITINGLeuven, 3000, Belgium
-
University of Illinois Chicago
RECRUITINGChicago, Illinois, 60612, United States
-
University of Southern California, Norris Comprehensive Cancer Center
RECRUITINGLos Angeles, California, 90033, United States
-
University of Texas MD Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Uniwersyteckie Centrum Kliniczne
RECRUITINGGdansk, 80-214, Poland
-
Wakayama Medical University Hospital
RECRUITINGWakayama, Wakayama, 641-8510, Japan
-
Wojewodzki Szpital im Sw Ojca Pio w Przemyslu
RECRUITINGPrzemyśl, 37-700, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Two-Drug attack shrink tough lung cancers?
- Can a smartphone app ease the burden of advanced lung cancer?
- Cholesterol-Lowering drug may boost lung cancer immunotherapy
- Lung cancer drug tislelizumab under Real-World scrutiny in 440-Patient european study
- New combo shows promise for tough lung cancer
- New hope for tough lung cancer: combo therapy enters phase II trial